STRATA Skin Sciences' TheraClear®X Acne Therapy System Found to be Safe and Effective for Acne Lesions Across All Fitzpatrick Skin Types with Favorable Tolerability and Patient Satisfaction as Published in Peer Reviewed Journal

Core Insights - STRATA Skin Sciences, Inc. announced positive clinical study results for its TheraClear®X Acne System, demonstrating significant efficacy and safety in treating mild to moderate acne [4][3] - The study showed a notable reduction in acne lesions, with two-thirds of participants achieving at least a one-grade improvement in Investigator's Global Assessment by Day 49 [1][3] - High patient satisfaction was reported, with 80% of participants expressing satisfaction or high satisfaction with the treatment [1][3] Company Overview - STRATA Skin Sciences is a medical technology company focused on developing and marketing innovative products for dermatologic conditions, including acne, psoriasis, and vitiligo [10] - The TheraClear®X device is FDA-cleared and utilizes a combination of gentle vacuum and pulsed broadband light to treat various forms of acne [8] - The company employs a unique Partnership Program that includes a fee per treatment cost structure, providing training and support for practitioners [10][11] Study Details - The clinical study titled "A 7-Week Open-Label Trial Evaluating the Safety and Efficacy of TheraClear®X for Mitigating Mild-to-Moderate Acne" was published in the Journal of Clinical and Aesthetic Dermatology [4] - Conducted by Dr. Glynis Ablon, the study involved six weekly treatment sessions and highlighted the device's customizable settings for tailored treatment [3][5] - The results indicated that TheraClear®X is a viable option for patients who have not responded well to other acne treatments [3]